Skip to main content

and
Your search also matched 4 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 Study

Include preview-only content
  1. Article

    Open Access

    Efficacy of Guselkumab in Treating Nails, Scalp, Hands, and Feet in Patients with Psoriasis and Self-reported Psoriatic Arthritis

    The aim of this study was to evaluate guselkumab efficacy on regional psoriasis in a subset of psoriasis patients with a self-reported psoriatic arthritis (PsA) diagnosis.

    Ana-Maria Orbai, Soumya D. Chakravarty, Yin You, May Shawi in Dermatology and Therapy (2023)

  2. Article

    Open Access

    DNA methylation-free Arabidopsis reveals crucial roles of DNA methylation in regulating gene expression and development

    A contribution of DNA methylation to defense against invading nucleic acids and maintenance of genome integrity is uncontested; however, our understanding of the extent of involvement of this epigenetic mark i...

    Li He, Huan Huang, Mariem Bradai, Cheng Zhao, Yin You, Jun Ma in Nature Communications (2022)

  3. Article

    Open Access

    Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies

    Health-related quality of life (HRQoL) may be markedly impaired in patients with moderate-to-severe psoriasis.

    April W. Armstrong, Kristian Reich, Peter Foley in American Journal of Clinical Dermatology (2019)